| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.25B | 126.27B | 130.80B | 145.76B | 124.28B | 103.47B |
| Gross Profit | 8.03B | 13.15B | 8.32B | 12.26B | 17.96B | 13.26B |
| EBITDA | 3.90B | 8.17B | 2.88B | 8.44B | 14.82B | 10.49B |
| Net Income | -5.18B | -1.46B | -46.45B | 794.00M | 7.92B | 5.51B |
Balance Sheet | ||||||
| Total Assets | 95.22B | 99.30B | 108.44B | 143.00B | 145.80B | 113.64B |
| Cash, Cash Equivalents and Short-Term Investments | 10.22B | 20.98B | 13.41B | 9.54B | 7.93B | 5.93B |
| Total Debt | 73.34B | 73.53B | 75.85B | 66.42B | 66.51B | 49.97B |
| Total Liabilities | 86.31B | 89.21B | 105.73B | 92.47B | 99.83B | 72.17B |
| Stockholders Equity | 8.90B | 10.08B | 2.71B | 50.52B | 45.96B | 41.46B |
Cash Flow | ||||||
| Free Cash Flow | 1.31B | 1.31B | -1.02B | 7.94B | -7.83B | 1.58B |
| Operating Cash Flow | 2.90B | 2.90B | 3.75B | 11.01B | -5.18B | 4.31B |
| Investing Cash Flow | -370.00M | -370.00M | -7.61B | -8.13B | -8.40B | 45.00M |
| Financing Cash Flow | 5.03B | 5.03B | 7.69B | -1.37B | 15.57B | -6.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥122.53B | 6.59 | 11.58% | 1.62% | 9.81% | 30.20% | |
68 Neutral | ¥2.43T | 7.93 | 5.18% | 1.98% | 3.15% | -63.65% | |
68 Neutral | ¥83.47B | 7.97 | ― | 2.98% | 8.89% | 102.20% | |
66 Neutral | ¥618.35B | 3.88 | 3.12% | 2.83% | -0.64% | -65.65% | |
66 Neutral | ¥518.27B | 22.37 | 5.02% | 2.12% | -7.98% | -42.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
46 Neutral | ¥15.68B | 1.14 | -111.61% | ― | -11.92% | 61.16% |